This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Ian Thompson
Vice President Business Development at Ypsomed AG

Profile

Ian Thompson has been with Ypsomed since 1995 in a number of roles in key account management and business development working with pharma companies to develop and bring to market innovative self-injection systems. He studied biochemistry and biotechnology in the UK and has worked in medical device companies since moving to Switzerland in 1990.

Since 2003 his main focus has been business development and new product innovation leading to the successful development and launch of a range of new pen and autoinjector Custom Products. Ypsomed Delivery Systems continues to focus on the development and manufacture of next generation pen, autoinjector, wearable and connected injector technologies.

Agenda Sessions

  • Self-Injection Trends and the Platform Approach for Peptide and Oligonucleotide Delivery

    6:00am
  • Self-Injection Trends and the Platform Approach for Peptide and Oligonucleotide Delivery

    6:00am